According to the latest report by IMARC Group, titled, “Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” The global metabolomics market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2027, exhibiting a CAGR of 12% during 2022-2027.
Metabolomics refers to the study of metabolites, small molecule substrates, intermediates and products of metabolism. It is used for phenotyping of genetically modified plants, identifying gene function and analyzing biotic-abiotic stress reaction. It helps researchers and scientists in calculating the physiological effects and metabolism of drugs. At present, the demand for metabolomics is escalating as it offers an assessment of health as well as causes and treatment of different medical ailments.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/metabolomics-market/requestsample
Metabolomics Market Trends and Drivers:
The thriving healthcare industry is one of the key factors driving the market growth. In line with this, metabolomics is extensively employed in the healthcare industry for the discovery and optimization of a lead compound and identification of biomarkers, which is contributing to the market growth significantly. Apart from this, the increasing demand for personalized medicines and technological advancements in analytical techniques is further bolstering the market growth. Other factors, such as the growing geriatric population and rising investments by governments of several countries on healthcare infrastructure, are expected to drive the market in the upcoming years.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Agilent Technologies, Inc. (A)
- Biocrates Life Sciences AG
- Bio-Rad Laboratories, Inc. (BIO)
- Bruker Corporation (BRKR)
- Danaher Corporation (DHR)
- HUMAN METABOLOME TECHNOLOGIES I (6090.T)
- Metabolon Inc.
- SHIMADZU CORP (SHMZF)
- Thermo Fisher Scientific Inc.
- Waters Corporation, etc.
Metabolomics Market 2022-2027 Competitive Analysis and Segmentation:
The report has segmented the market based on product, indication and application.
Insights on Market Segmentation:
Market Breakup by Product:
- Metabolomics Instruments
- Metabolomics Bioinformatics Tools and Services
Market Breakup by Indication:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Inborn Errors of Metabolism
- Others
Market Breakup by Application:
- Biomarker and Drug Discovery
- Toxicology
- Nutrigenomics
- Personalized Medicine
- Others
Market Segmentation by Region:
- North America
- Asia Pacific
- Europe
- United Kingdom
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/metabolomics-market
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Other Reports By IMARC Group:
Patient Centric Healthcare App Market Report
India E-Commerce Market Report
India Electric Vehicle Charging Station Market Report
India Automotive Wiring Harness Market Report
India Luxury Car Market Report
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800